Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
The #FDA is stepping up efforts to encourage wider adoption of new clinical trial methods, issuing new guidance documents Thursday intended to help innovators and clinical researchers design more efficient, modern, and less costly studies. https://t.co/Q0QOPVDGqp
SteveFDA (R-D.C.)
@SGottliebFDA
As part of our ongoing efforts to enhance the safety of medical devices, we’ve been taking a close look at new advances in device materials and whether our regulations should change to ensure patients are protected. https://t.co/KMlZ6ow7kc https://t.co/sp65kAPFXi
SteveFDA (R-D.C.)
@SGottliebFDA
RT @LimOpinion: New from FDA: @SGottliebFDA and Shuren saying the agency is taking a closer look at device materials. "We believe… https://t.co/STlHG5woBC
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAJobs: #FlashbackFriday @SGottliebFDA at the White Oak Classic in Silver Spring, MD. #fridayfavorites #FDA (I bet he has s… https://t.co/Y8tARmbJ20
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: Read @SGottliebFDA’s statement on continuing efforts to evaluate materials in medical devices to address potential… https://t.co/P6Fz1IGfCA
SteveFDA (R-D.C.)
@SGottliebFDA
While we do a careful biocompatibility evaluation of devices before they’re marketed, we recognize the importance of advancing the science we rely on to evaluate device materials and patient risk factors.
SteveFDA (R-D.C.)
@SGottliebFDA
We’ve heard from concerned patients asking whether materials in their device implants may be connected to immune system conditions, resulting in symptoms like chronic fatigue, cognitive issues and muscle pain. Today we’re sharing what we’ve been doing and what to expect next.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: We are continuing our efforts to curb opioid addiction & abuse by cracking down on illegal online sales of opioids.… https://t.co/iZhT3K5pIQ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @allison_maass: The latest NYTS survey found 1.5 million more students used e-cigarettes between 2017 and 2018. @GrayDCnews sat dow… https://t.co/nHnv1FDSVB
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PharmaPinkSheet: Cancer Trials: US FDA Guidances Aim To Expand Eligibility Criteria And Better Inform Labeling https://t.co/NbUVaaxPfu #PinkSheet
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: The latest in-season #flu estimates from @CDCFlu show that more than 25 million people have been sick with flu this… https://t.co/nCaKcRWM8X
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FrankYiannasFDA: There’s a strong public health & business case for better food traceability. And new tools now make it more possibl… https://t.co/NHFkDaEpXm
SteveFDA (R-D.C.)
@SGottliebFDA
But we’ve been rethinking our strategy amid new data showing an epidemic-level rise in youth e-cig use. The 2018 National Youth Tobacco Survey (NYTS) found that over 3.6 million middle & high school students currently used e-cigs, from 2.1 million in 2017 https://t.co/P1FeBBOnQv https://t.co/knV151x5fI
SteveFDA (R-D.C.)
@SGottliebFDA
Our plan: To regulate nicotine in combustible tobacco to render cigarettes minimally or non-addictive at the same time we advanced a path for e-cigs as a potentially less harmful alternative for adults who still wanted access to nicotine that was no longer available in cigarettes
SteveFDA (R-D.C.)
@SGottliebFDA
I saw the chance to advance new technologies like electronic cigarettes as part of that plan. We saw these products as potentially less harmful alternatives to cigarettes for some adult smokers seeking access to nicotine, without all the deadly effects of combustion. https://t.co/8yPkcTD8e3
SteveFDA (R-D.C.)
@SGottliebFDA
To explain, let’s go back a bit in time to see how this issue has evolved. In 2017, early after I became commissioner, #FDA was poised to put us on a path to overcome one of the most pernicious public health challenges of our times – death and disease caused by cigarette smoking.
SteveFDA (R-D.C.)
@SGottliebFDA
The U.S. is facing a new epidemic sparked by the surging popularity of e-cig use by kids. Halting this public health crisis requires forceful steps from FDA. In today’s #FDA #SundayTweetorial I’ll detail what we advanced last week – and why. And what additional steps we may take. https://t.co/LpFlDopJax
SteveFDA (R-D.C.)
@SGottliebFDA
The NYTS data are especially troubling - they don’t just show that more kids are experimenting with e-cigs, they show many teens already use them on a regular basis. I’m worried that by the next survey, even more kids will be heavily addicted to e-cigs. So, we have to act now.
SteveFDA (R-D.C.)
@SGottliebFDA
E-cigarettes deliver nicotine to your brain quickly, which can keep you using once you start, even if you want to stop. And some may e-cigarettes contain as much as nicotine as 20 cigarettes.
SteveFDA (R-D.C.)
@SGottliebFDA
Why the concern? We know that most e-cigs contain nicotine – a highly-addictive substance that can rewire teen brains to make them want more of it. Nicotine exposure can affect brain development in youth and may have long-lasting effects including impulse control, mood disorders https://t.co/8Trfx2pvQO